Live Analyst Rating Changes 2209 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Derek Lessard
TD
Derek Lessard
TD Cowen
Wall Street Analyst
Not yet ranked — too few measurable calls.
0%
Success Rate
-2.0%
Average Return
0 of 1 calls profitable · -4.2% vs benchmark
📈 Across the calls we could measure, roughly 0% of Derek Lessard's ratings turned a profit when each position was held for 2 year — averaging -2.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 16 Hold 3 Sell
Derek's Stock Coverage 17 ratings · 2026-06-24
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return
TSE:DB
Decibel Cannabis Company
 May 22, 2026 BUY Strong Buy
+110.6% avg upside
4 analysts
$0.25
108.23% Upside
 ·
TSE:PZA
Pizza Pizza Royalty
 May 19, 2026 HOLD Hold
-6.9% avg upside
1 analyst
$12.00
6.88% Downside
 ·
TSE:AGTF
AGT Food and Ingredients Inc
 May 14, 2026 HOLD Strong Buy
+35.8% avg upside
5 analysts
$20.00
15.22% Upside
 ·
TSE:BYD
Boyd Group Services
 May 14, 2026 BUY Strong Buy
+85.0% avg upside
19 analysts
$190.00
48.18% Upside
 ·
TSE:CRON
Cronos Group
 May 12, 2026 BUY Buy
+83.5% avg upside
12 analysts
$5.50
44.38% Upside
 ·
TSE:DII.B
Dorel Class B
 May 11, 2026 HOLD Hold
+57.2% avg upside
4 analysts
$2.00
26.54% Upside
 ·
PRMB
Primo Brands
 May 07, 2026 BUY Strong Buy
+2.0% avg upside
21 analysts
$29.00
18.73% Upside
 -2.0%
TSE:KBL
K-Bro Linen
 May 07, 2026 BUY Strong Buy
+1.3% avg upside
4 analysts
$52.00
19.63% Upside
 ·
TSE:SIS
Savaria
 May 07, 2026 BUY Strong Buy
+8.0% avg upside
6 analysts
$35.00
24.07% Upside
 ·
TSE:LOVE
Cannara Biotech
 Apr 15, 2026 BUY Strong Buy
+90.5% avg upside
3 analysts
$3.25
104.50% Upside
 ·
TSE:MTY
MTY Food Group
 Apr 10, 2026 HOLD Hold
+33.0% avg upside
7 analysts
$42.00
13.49% Upside
 ·
TSE:HITI
High Tide
 Feb 24, 2026 BUY Strong Buy
+124.2% avg upside
8 analysts
$6.50
105.15% Upside
 ·
TSE:JWEL
Jamieson Wellness Inc
 Aug 08, 2025 BUY Buy
+10.4% avg upside
8 analysts
$45.00
23.44% Upside
 ·
TSE:PBH
Premium Brands
 Jul 18, 2025 BUY Strong Buy
+34.7% avg upside
13 analysts
$140.00
66.07% Upside
 ·
TSE:CGX
Cineplex
 Apr 16, 2025 BUY Buy
+21.4% avg upside
9 analysts
$16.00
35.33% Upside
 ·
TSE:ACB
Aurora Cannabis
 Feb 06, 2025 BUY Hold
+896.1% avg upside
14 analysts
$10.00
142.70% Upside
 ·
TSE:DII.A
Dorel Ind Inc A MV
 Nov 05, 2018 HOLD Hold
+959.0% avg upside
3 analysts
$32.59
1554.30% Upside
 ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Derek Lessard — Frequently Asked Questions
How accurate are Derek Lessard's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Derek's ratings were profitable over a one-year hold, with an average return of -2.0% per rating, or -4.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Derek ranked on 13Foresight?
Derek Lessard is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Derek cover?
Derek most recently has ratings on TSE:DB, TSE:PZA, TSE:AGTF, TSE:BYD, TSE:CRON, TSE:DII.B, PRMB, TSE:KBL, TSE:SIS, TSE:LOVE, TSE:MTY, TSE:HITI and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.